Want to see IN:CAMLINFINE full AI Analyst Report?
CAMLINFINE Stock Chart & Stats
₹129.15
-₹4.44(-3.41%)
At close: 4:00 PM EDT
₹129.15
-₹4.44(-3.41%)
Day’s Range― - ―
52-Week Range₹88.27 - ₹204.35
Previous CloseN/A
Volume328.64K
Average Volume (3M)44.40K
Market Cap
₹17.28B
Enterprise Value₹24.10B
Total Cash (Recent Filing)₹1.09B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)346.1
Beta0.80
Next Earnings
Nov 05, 2026EPS Estimate
-0.4Next Dividend Ex-DateN/A
Dividend Yield0.47%
Share Statistics
EPS (TTM)0.26
Shares Outstanding192,096,620
10 Day Avg. Volume44,232
30 Day Avg. Volume44,395
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.76
Price to Sales (P/S)1.06
P/FCF Ratio-55.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.6
Revenue Forecast (FY)₹21.16B
Bulls Say, Bears Say
Bulls Say
Improved LeverageLower leverage and a larger equity base improve financial resilience compared with FY2023. This gives Camlin Fine Sciences more capacity to manage operating volatility and support investment, although the balance sheet remains meaningfully leveraged for a specialty chemicals company.
Return To ProfitabilityReturning to positive net income shows that the business retains an ability to produce earnings despite recent volatility. If profitability can be sustained, it could restore internal funding capacity and provide a foundation for rebuilding margins after the losses recorded in FY2024 and FY2025.
Specialty Ingredient PositioningServing multiple end markets with shelf-life, stability, and performance ingredients gives the company a diversified specialty-chemicals platform. Customer-specific blends and application know-how can support recurring B2B demand and value-added pricing beyond purely commodity product sales.
Bears Say
Sharp Revenue ContractionThe steep FY2026 revenue decline indicates that recent demand or business execution has been highly inconsistent. Sustained contraction would reduce operating leverage, weaken customer and market momentum, and make it harder for the company to support investment or return to a stable growth trajectory.
Compressed Profit MarginsMaterial margin compression has reduced the earnings generated from each unit of revenue and leaves limited room for operational or demand setbacks. Thin net profitability also makes future earnings more sensitive to product mix, input costs, pricing execution, and capacity utilization.
Weak Cash ConversionNegative free cash flow despite positive net income signals that accounting profitability is not consistently converting into deployable cash. This can constrain debt reduction, reinvestment, and shareholder returns, while the unstable historical pattern raises concern about working-capital needs or ongoing cash reinvestment.
Camlin Fine Sciences Limited News
CAMLINFINE FAQ
What was Camlin Fine Sciences Limited’s price range in the past 12 months?
Camlin Fine Sciences Limited lowest stock price was ₹88.27 and its highest was ₹204.35 in the past 12 months.
What is Camlin Fine Sciences Limited’s market cap?
Camlin Fine Sciences Limited’s market cap is ₹17.28B.
When is Camlin Fine Sciences Limited’s upcoming earnings report date?
Camlin Fine Sciences Limited’s upcoming earnings report date is Nov 05, 2026 which is in 23 days.
How were Camlin Fine Sciences Limited’s earnings last quarter?
Camlin Fine Sciences Limited released its earnings results on Aug 11, 2026. The company reported -₹0.9 earnings per share for the quarter, missing the consensus estimate of ₹0.12 by -₹1.02.
Is Camlin Fine Sciences Limited overvalued?
According to Wall Street analysts Camlin Fine Sciences Limited’s price is currently Overvalued.
Does Camlin Fine Sciences Limited pay dividends?
Camlin Fine Sciences Limited pays a Annually dividend of ₹0.45 which represents an annual dividend yield of 0.47%. See more information on Camlin Fine Sciences Limited dividends here
What is Camlin Fine Sciences Limited’s EPS estimate?
Camlin Fine Sciences Limited’s EPS estimate is -0.4.
How many shares outstanding does Camlin Fine Sciences Limited have?
Camlin Fine Sciences Limited has 192,096,620 shares outstanding.
What happened to Camlin Fine Sciences Limited’s price movement after its last earnings report?
Camlin Fine Sciences Limited reported an EPS of -₹0.9 in its last earnings report, missing expectations of ₹0.12. Following the earnings report the stock price went up 0.684%.
Which hedge fund is a major shareholder of Camlin Fine Sciences Limited?
Currently, no hedge funds are holding shares in IN:CAMLINFINE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, an India-based company headquartered in Mumbai and established in 1931 (originally as Camlin Fine Chemicals Limited until August 2011), is involved in the global research, development, production, and distribution of a diverse range of specialty chemicals, ingredients, and additive formulations. The company offers extensive shelf-life extension solutions under its Xtendra and NaSure brands. These include various antioxidants such as Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, alongside natural alternatives like mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Additionally, its offerings comprise mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Its product line also features aroma ingredients, notably vanillin and ethyl vanillin, as well as nutraceuticals sourced through fermentation and plant extraction processes. Furthermore, Camlin Fine Sciences provides performance chemicals like hydroquinone and catechol, and a selection of downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, and HQEE. These versatile products cater to numerous industries worldwide, encompassing food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemicals, agrochemicals, pharmaceuticals, polymers, dyes and pigments, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplements. The company actively engages in international exports of its goods.
Technical Analysis
Fineotex Chemical Limited
―
GOCL Corporation Limited
―
Kiri Industries Limited
―
NOCIL Limited
―
Rossari Biotech Ltd
―








